Advanced Medical Optics' Tecnis designated as a new technology by Medicare, Medicaid

By Lisa Kerner

Erie, Pa., Jan. 26 - Advanced Medical Optics, Inc. said its Tecnis foldable intraocular lens (IOL) has been designated as a New Technology Intraocular Lens (NTIOL) by the Centers for Medicare and Medicaid Services.

The Tecnis IOL is the only lens approved for NTIOL reimbursement status, which provides for additional Medicare reimbursement of $50 per lens for ambulatory surgical centers, the company said.

The designation follows labeling claims approved by the Food and Drug Administration in April 2004. The company claims the Tecnis foldable IOL reduced postoperative spherical aberrations compared to lenses with spherical optics and improved night driving simulator performance.

The NTIOL designation goes into effect Feb. 27 and includes both the acrylic and silicone platform Tecnis lenses.

The Tecnis foldable IOL is indicated for primary implantation for visual correction of aphakia in adults who have had a cataractous lens removed by phacoemulsification, the company said.

Advanced Medical Optics acquired the Tecnis foldable IOL, along with the CeeOn IOL, Baerveldt glaucoma shunt, and Healon family of ophthalmic viscosurgical devices from Pfizer in June 2004.

Santa Ana, Calif.-based Advanced Medical Optics is a global medical device company focused on vision technologies.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.